S&P 500   4,185.05 (+0.96%)
DOW   33,106.65 (+0.92%)
QQQ   324.24 (+0.77%)
AAPL   166.49 (+0.69%)
MSFT   284.13 (+0.43%)
META   172.30 (+3.11%)
GOOGL   118.37 (+0.77%)
AMZN   143.69 (+2.05%)
TSLA   888.29 (+2.75%)
NVDA   179.28 (-5.59%)
NIO   20.60 (+1.88%)
BABA   91.80 (-0.82%)
AMD   101.23 (-1.06%)
MU   62.05 (-0.66%)
T   18.28 (-0.38%)
CGC   2.79 (+3.33%)
GE   76.35 (+2.68%)
F   15.77 (+3.07%)
DIS   108.90 (+2.13%)
AMC   25.95 (+17.00%)
PYPL   97.02 (+1.78%)
PFE   48.98 (-0.59%)
NFLX   229.60 (+1.24%)
S&P 500   4,185.05 (+0.96%)
DOW   33,106.65 (+0.92%)
QQQ   324.24 (+0.77%)
AAPL   166.49 (+0.69%)
MSFT   284.13 (+0.43%)
META   172.30 (+3.11%)
GOOGL   118.37 (+0.77%)
AMZN   143.69 (+2.05%)
TSLA   888.29 (+2.75%)
NVDA   179.28 (-5.59%)
NIO   20.60 (+1.88%)
BABA   91.80 (-0.82%)
AMD   101.23 (-1.06%)
MU   62.05 (-0.66%)
T   18.28 (-0.38%)
CGC   2.79 (+3.33%)
GE   76.35 (+2.68%)
F   15.77 (+3.07%)
DIS   108.90 (+2.13%)
AMC   25.95 (+17.00%)
PYPL   97.02 (+1.78%)
PFE   48.98 (-0.59%)
NFLX   229.60 (+1.24%)
S&P 500   4,185.05 (+0.96%)
DOW   33,106.65 (+0.92%)
QQQ   324.24 (+0.77%)
AAPL   166.49 (+0.69%)
MSFT   284.13 (+0.43%)
META   172.30 (+3.11%)
GOOGL   118.37 (+0.77%)
AMZN   143.69 (+2.05%)
TSLA   888.29 (+2.75%)
NVDA   179.28 (-5.59%)
NIO   20.60 (+1.88%)
BABA   91.80 (-0.82%)
AMD   101.23 (-1.06%)
MU   62.05 (-0.66%)
T   18.28 (-0.38%)
CGC   2.79 (+3.33%)
GE   76.35 (+2.68%)
F   15.77 (+3.07%)
DIS   108.90 (+2.13%)
AMC   25.95 (+17.00%)
PYPL   97.02 (+1.78%)
PFE   48.98 (-0.59%)
NFLX   229.60 (+1.24%)
S&P 500   4,185.05 (+0.96%)
DOW   33,106.65 (+0.92%)
QQQ   324.24 (+0.77%)
AAPL   166.49 (+0.69%)
MSFT   284.13 (+0.43%)
META   172.30 (+3.11%)
GOOGL   118.37 (+0.77%)
AMZN   143.69 (+2.05%)
TSLA   888.29 (+2.75%)
NVDA   179.28 (-5.59%)
NIO   20.60 (+1.88%)
BABA   91.80 (-0.82%)
AMD   101.23 (-1.06%)
MU   62.05 (-0.66%)
T   18.28 (-0.38%)
CGC   2.79 (+3.33%)
GE   76.35 (+2.68%)
F   15.77 (+3.07%)
DIS   108.90 (+2.13%)
AMC   25.95 (+17.00%)
PYPL   97.02 (+1.78%)
PFE   48.98 (-0.59%)
NFLX   229.60 (+1.24%)
TSE:NWH.UN

NorthWest Health Prop Real Est Inv Trust (NWH.UN) Price Target & Analyst Ratings

C$13.09
+0.05 (+0.38%)
(As of 08/8/2022 09:45 AM ET)
Add
Compare
Today's Range
C$13.05
C$13.11
50-Day Range
C$11.91
C$13.21
52-Week Range
C$11.85
C$14.42
Volume
27,369 shs
Average Volume
498,427 shs
Market Capitalization
C$3.11 billion
P/E Ratio
7.23
Dividend Yield
6.14%
Price Target
C$15.22

NorthWest Health Prop Real Est Inv Trust Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

C$15.22
16.29% Upside
High PredictionC$16.25
Average PredictionC$15.22
Low PredictionC$13.75
TypeCurrent
8/8/21 to 8/8/22
1 Month Ago
7/9/21 to 7/9/22
3 Months Ago
5/10/21 to 5/10/22
1 Year Ago
8/8/20 to 8/8/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
0 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$15.22C$15.08C$15.38C$13.75
Predicted Upside16.29% Upside10.50% Upside10.66% Upside7.57% Upside
Get NorthWest Health Prop Real Est Inv Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NWH.UN and its competitors with MarketBeat's FREE daily newsletter.


NWH.UN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NWH.UN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NorthWest Health Prop Real Est Inv Trust Stock vs. The Competition

TypeNorthWest Health Prop Real Est Inv TrustReal Estate Companies
Consensus Rating Score
2.43
2.50
Consensus RatingHoldBuy
News Sentiment RatingNeutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
113
37.92%
Underperform Votes
185
62.08%
Avg. Outperform Votes
113
63.84%
Avg. Underperform Votes
64
36.16%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/20/2022National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector PerformC$16.25+28.66%
7/4/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jenny Ma
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ BuyC$15.00 ➝ C$13.75+12.06%
6/27/2022CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$15.50 ➝ C$14.75+20.51%
3/17/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector PerformC$14.50 ➝ C$15.00+4.68%
3/17/2022Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector PerformC$15.00 ➝ C$15.50+8.16%
3/16/2022Laurentian Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuyC$16.00+13.64%
3/16/2022Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$15.25 ➝ C$15.75+11.78%
8/19/2021National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector PerformC$14.00+8.61%
(Data available from 8/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NorthWest Health Prop Real Est Inv Trust Price Target - Frequently Asked Questions

What is NorthWest Health Prop Real Est Inv Trust's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for NorthWest Health Prop Real Est Inv Trust stock is Hold based on the current 4 hold ratings and 3 buy ratings for NWH.UN. The average twelve-month price prediction for NorthWest Health Prop Real Est Inv Trust is C$15.22 with a high price target of C$16.25 and a low price target of C$13.75. Learn more on NWH.UN's analyst rating history.

Do Wall Street analysts like NorthWest Health Prop Real Est Inv Trust more than its competitors?

Analysts like NorthWest Health Prop Real Est Inv Trust less than other Real Estate companies. The consensus rating score for NorthWest Health Prop Real Est Inv Trust is 2.43 while the average consensus rating score for real estate companies is 2.49. Learn more on how NWH.UN compares to other companies.

Do MarketBeat users like NorthWest Health Prop Real Est Inv Trust more than its competitors?

MarketBeat users like NorthWest Health Prop Real Est Inv Trust less than other Real Estate companies. 37.92% of MarketBeat users gave NorthWest Health Prop Real Est Inv Trust an outperform vote while real estate companies recieve an average of 63.19% outperform votes by MarketBeat users.

Is NorthWest Health Prop Real Est Inv Trust being upgraded by Wall Street analysts?

Over the previous 90 days, NorthWest Health Prop Real Est Inv Trust's stock had 1 upgrade by analysts.

Does NorthWest Health Prop Real Est Inv Trust's stock price have much upside?

According to analysts, NorthWest Health Prop Real Est Inv Trust's stock has a predicted upside of 13.28% based on their 12-month price targets.

What analysts cover NorthWest Health Prop Real Est Inv Trust?

NorthWest Health Prop Real Est Inv Trust has been rated by BMO Capital Markets, CIBC, and National Bankshares in the past 90 days.


Stock Ratings Reports and Tools

This page (TSE:NWH.UN) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.